No Data
No Data
Announcement Highlights | "Flash" placement! NIO plans to issue no more than 0.119 billion shares; Semiconductor Manufacturing International Corporation's revenue is expected to grow nearly 28% year-on-year in 2024.
CNOOC's net profit in 2024 exceeds 130 billion yuan; New China Life Insurance's annual profit increased approximately twofold year-on-year.
The Earnings Reports show a strong profit trend, is Yonghe Medical (2279.HK) undervalued?
Recently, the State Council's General Office released the "Special Action Plan to Boost Consumer Spending," which clearly states that measures such as increasing income for urban and rural residents and ensuring consumer purchasing power will be implemented to unleash the potential for residents' medical consumption. Among them, consumer medical services, as an important branch of discretionary spending, are expected to benefit from the increased health awareness and improved payment ability of residents, with demand likely to continue recovering. With policy support, private medical Institutions and high-end medical instruments may see opportunities for expansion in their respective segments. Therefore, for those enterprises that have long been troubled by market discounts, this is a critical juncture for valuation restructuring, especially as it coincides with the new round of Earnings Reports season, which offers investors.
Yonghe Medical Group Reports Improved Financial Performance for 2024
Yonghe Medical (02279.HK) announced its annual performance, achieving a profit of 0.141 billion yuan before interest, taxes, depreciation, and amortization.
On March 27, Guolonghui reported that Yonghe Medical (02279.HK) announced that for the year ending December 31, 2024, the group's revenue increased by 1.5% to RMB 1,804.5 million. The group's gross profit increased by 8.7% to RMB 1,084.2 million. The gross margin rose from 56.1% in the previous year to 60.1% for the year ending December 31, 2024. The group's net loss decreased by 58.6% from RMB 546.7 million in the previous year to a net loss of RMB 226.6 million for the year ending December 31, 2024. As of 20
YONGHE MEDICAL: ANNOUNCEMENT OF THE ANNUAL RESULTSFOR THE YEAR ENDED 31 DECEMBER 2024
Yonghe Medical Group Schedules Board Meeting for Year-End Results